Shanghai Shyndec Pharmaceutical Co., Ltd. (SHA:600420)

SHA:600420 Revenue

Shanghai Shyndec Pharmaceutical had revenue of 2.06B CNY in the quarter ending March 31, 2026, a decrease of -20.81%. This brings the company's revenue in the last twelve months to 8.82B, down -15.36% year-over-year. In the year 2025, Shanghai Shyndec Pharmaceutical had annual revenue of 9.36B, down -14.39%.

• Revenue (ttm): 8.82B
• Revenue Growth: -15.36%
• P/S Ratio: 1.40
• Revenue / Employee: 909.62K
• Employees: 9,697
• Market Cap: 12.34B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	9.36B	-1.57B	-14.39%
Dec 31, 2024	10.94B	-1.13B	-9.38%
Dec 31, 2023	12.07B	-889.39M	-6.86%
Dec 31, 2022	12.96B	-985.63M	-7.07%
Dec 31, 2021	13.94B	1.39B	11.06%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 17, 2026

Data Sources Report a data error